Related Experiment Video
Updated: Jan 23, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the
Natalia A Muraleva1, Oyuna S Kozhevnikova2, Anzhela Z Fursova3
1Institute of Cytology and Genetics SB RAS, Pr. Lavrentyeva 10, Novosibirsk 630090, Russia. Myraleva@bionet.nsc.ru.
Abstract:
Age-related macular degeneration (AMD) is a major cause of irreversible visual impairment and blindness in developed countries, and the molecular pathogenesis of AMD is poorly understood. Recent studies strongly indicate that amyloid β (Aβ) accumulation -found in the brain and a defining feature of Alzheimer's disease-also forms in the retina in both Alzheimer's disease and AMD. The reason why highly neurotoxic proteins of consistently aggregate in the aging retina, and to what extent they contribute to AMD, remains to be fully addressed. Nonetheless, the hypothesis that Aβ is a therapeutic target in AMD is debated. Here, we showed that long-term treatment with SkQ1 (250 nmol/[kg body weight] daily from the age of 1.5 to 22 months) suppressed the development of AMD-like pathology in senescence-accelerated OXYS rats by reducing the level of Aβ and suppressing the activity of mTOR in the retina. Inhibition of mTOR signaling activity, which plays key roles in aging and age-related diseases, can be considered a new mechanism of the prophylactic effect of SkQ1. It seems probable that dietary supplementation with mitochondria-targeted antioxidant SkQ1 can be a good prevention strategy to maintain eye health and possibly a treatment of AMD.
Insights
Mitochondria-targeted antioxidant SkQ1 suppressed age-related macular degeneration (AMD) progression in rats by reducing retinal amyloid beta (Aβ) and inhibiting mTOR signaling. SkQ1 may offer a new prevention strategy for maintaining eye health and treating AMD.
Area of Science:
- Ophthalmology
- Neuroscience
- Gerontology
Background:
- Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss.
- Amyloid beta (Aβ) accumulation, implicated in Alzheimer's disease, is also found in the retina of AMD patients.
- The precise role of Aβ in AMD pathogenesis and its potential as a therapeutic target are under investigation.
Purpose of the Study:
- To investigate the potential of SkQ1, a mitochondria-targeted antioxidant, in preventing AMD-like pathology.
- To explore the molecular mechanisms underlying SkQ1's effects, specifically focusing on Aβ and mTOR signaling in the retina.
Main Methods:
- Long-term administration of SkQ1 to senescence-accelerated OXYS rats from 1.5 to 22 months of age.
- Assessment of AMD-like pathology development in the retina.
- Quantification of amyloid beta (Aβ) levels and measurement of mTOR signaling activity in the retina.
Main Results:
- SkQ1 treatment significantly suppressed the development of AMD-like pathology in OXYS rats.
- Retinal Aβ levels were reduced in SkQ1-treated rats compared to controls.
- SkQ1 administration suppressed mTOR signaling activity in the retina.
Conclusions:
- Inhibition of mTOR signaling represents a novel mechanism for the prophylactic effects of SkQ1 against AMD.
- Dietary supplementation with SkQ1 shows promise as a preventative strategy for maintaining eye health.
- SkQ1 may serve as a potential therapeutic agent for age-related macular degeneration.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Decreasing Function
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...

